We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ELAT market cap is 10.5B. The company's latest EPS is USD -2.4986 and P/E is -5.15.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.26B | 1.06B | 1.07B | 1.04B | 1.21B |
| Operating Income | 181M | 18M | -1.01B | -5M | 87M |
| Net Income | 103M | -97M | -1.1B | -141M | 32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.07B | 3.28B | 4.77B | 4.41B | 4.42B |
| Operating Income | 174.3M | -696.1M | -48M | 201M | -817M |
| Net Income | 67.9M | -560.1M | -472M | -78M | -1.23B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.77B | 15.8B | 14.34B | 14.36B | 14.02B |
| Total Liabilities | 8.29B | 8.38B | 8.21B | 8.14B | 7.96B |
| Total Equity | 7.48B | 7.42B | 6.13B | 6.22B | 6.06B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.99B | 17.69B | 16.48B | 15.49B | 14.36B |
| Total Liabilities | 3.44B | 9.22B | 8.95B | 8.2B | 8.14B |
| Total Equity | 5.55B | 8.48B | 7.54B | 7.29B | 6.22B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -145M | -84M | 114M | 271M | 2M |
| Investing | -55M | -98M | -134M | -169M | 37M |
| Financing | 174M | 213M | 56M | -83M | -27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 224.1M | -41M | 483M | 452M | 271M |
| Investing | -234.8M | -4.78B | -530M | -179M | -169M |
| Financing | -304.8M | 4.95B | 210M | -549M | -83M |
| Market Cap | 10.5B |
| Price to Earnings Ratio | -5.15 |
| Price to Sales Ratio | 1.43 |
| Price to Cash Ratio | 18 |
| Price to Book Ratio | 1.02 |
| Dividend Yield | - |
| Shares Outstanding | 492.68M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 13.71 (40.16%) |
| Company Name | Elanco Animal Health Incorporated |
| Address |
135 north pennsylvania street indianapolis, indiana 46204 |
| Website | https://www.elanco.com |
| Industry | pharmaceutical preparations (2834) |
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
